Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

ClinicalTrials.gov ID: NCT04016779

Public ClinicalTrials.gov record NCT04016779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 12:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of SPN-812 (Viloxazine extended-release capsules; 200-600 mg) in adults 18-65 years of age with Attention-Deficit/Hyperactivity Disorder (ADHD).

Study identification

NCT ID
NCT04016779
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
374 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 20, 2019 (Actual)
Primary completion
Oct 10, 2020 (Actual)
Completion
Oct 10, 2020 (Actual)
Last update posted
Jul 12, 2022

2019 – 2020

United States locations

U.S. sites
37
U.S. states
14
U.S. cities
35
Facility City State ZIP Site status
Collaborative Neuroscience Network Garden Grove California 92845 —
Pharmacology Research Institute Los Alamitos California 90720 —
Pharmacology Research Institute Newport Beach California 92660 —
Artemis Research Institute for Clinical Research Riverside California 92078 —
Artemis Institute for Clinical Research San Diego California 92103 —
Artemis Institute for Clinical Research San Marcos California 92078 —
Collaborative Neuroscience Network LLC Torrance California 90502 —
Gulfcoast Research Center Fort Myers Florida 33912 —
Research Centers of America Hollywood Florida 33024 —
Clinical Neuroscience Solutions, Inc Jacksonville Florida 32217 —
Meridien Research Lakeland Florida 33805 —
Medical Research Group of Central Florida Orange City Florida 32763 —
Clinical Neuroscience Solutions Inc. Orlando Florida 32801 —
CNS Healthcare Orlando Florida 32806 —
Meridien Research Tampa Florida 33634 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
iResearch Atlanta Decatur Georgia 30030 —
Psych Atlanta Marietta Georgia 30060 —
Psychiatric Associates Overland Park Kansas 66211 —
St. Charles Psychiatric Associates Midwest Research Center Saint Charles Missouri 63304 —
Alivation Research, LLC Lincoln Nebraska 68526 —
Altea Research Institute Las Vegas Nevada 10549 —
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128 —
Hassman Research Institute Berlin New Jersey 08009 —
Center for Emotional Fitness Cherry Hill New Jersey 08002 —
Hassmann Research Institute Marlton New Jersey 08053 —
Princeton Medical Institute Princeton New Jersey 08540 —
Bioscience Research Mount Kisco New York 10549 —
The Medical Research Network LLC New York New York 10128r —
Paradigm Research Professionals Oklahoma City Oklahoma 73188 —
CNS Healthcare Memphis Tennessee 38119 —
BioBehavioral Research of Austin P.C. Austin Texas 78759 —
FutureSearch Trials of Dallas, LLP Dallas Texas 75231 —
Houston Clinical Trials Houston Texas 77098 —
Family Psychiatry of the Woodlands The Woodlands Texas 77381 —
Ericksen Research & Development Clinton Utah 84015 —
Northwest Clinical Trials Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04016779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2022 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04016779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →